DPX-Survivac, a novel T-cell immunotherapy, to induce robust T-cell responses in advanced ovarian cancer

Oliver Dorigo, Stephan Fiset, Lisa Diana MacDonald, Yogesh Bramhecha, Olga Hrytsenko, Brennan Dirk, Gabriela Nicola Rosu, Marianne Stanford

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 7|浏览23

暂无评分

摘要

6Background: Survivin has emerged as an attractive target for T cell-based immunotherapy because of its essential role in tumor biology and its tumor-specific expression in multiple tumor types. DP...

查看译文

关键词

advanced ovarian cancer,immunotherapy,dpx-survivac,t-cell

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要